glucagon has been researched along with ursodeoxycholic acid in 7 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (ursodeoxycholic acid) | Trials (ursodeoxycholic acid) | Recent Studies (post-2010) (ursodeoxycholic acid) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 4,592 | 626 | 1,561 |
| Protein | Taxonomy | glucagon (IC50) | ursodeoxycholic acid (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 3.6 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bygrave, FL; Hamada, Y; Karjalainen, A; Millard, JE; Setchell, BA | 1 |
| Crepaldi, G; Jemmolo, RM; Lirussi, F; Muraca, M; Nassuato, G; Okolicsanyi, L; Orlando, R; Strazzabosco, M | 1 |
| Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y | 1 |
| Bouscarel, B; Dubner, H; Fromm, H; Gettys, TW | 1 |
| Bouscarel, B; Ceryak, S; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y; Shoda, J | 1 |
| Bouscarel, B; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y | 1 |
| Bojsen-Moller, KN; Clausen, TR; Holst, JJ; Kristiansen, VB; Kuhre, RE; Madsbad, S; Nielsen, S; Rehfeld, JF; Svane, MS | 1 |
1 review(s) available for glucagon and ursodeoxycholic acid
| Article | Year |
|---|---|
The effect of drugs on bile flow and composition. An overview.
Topics: Animals; Bile; Bile Acids and Salts; Cats; Chlorpromazine; Cholagogues and Choleretics; Cholesterol; Clofibrate; Colchicine; Cricetinae; Dehydrocholic Acid; Diuretics; Dogs; Enterohepatic Circulation; Estrogens; Glucagon; Guinea Pigs; Humans; Insulin; Liver; Macaca mulatta; Phospholipids; Rabbits; Rats; Rifampin; Rifamycins; Somatostatin; Theophylline; Ursodeoxycholic Acid | 1986 |
1 trial(s) available for glucagon and ursodeoxycholic acid
| Article | Year |
|---|---|
Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Topics: Administration, Oral; Adult; Bile Acids and Salts; Blood Glucose; C-Peptide; Chenodeoxycholic Acid; Cross-Over Studies; Female; Fibroblast Growth Factors; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Ursodeoxycholic Acid | 2017 |
5 other study(ies) available for glucagon and ursodeoxycholic acid
| Article | Year |
|---|---|
Acute effects of cholestatic and choleretic bile salts on vasopressin- and glucagon-induced hepato-biliary calcium fluxes in the perfused rat liver.
Topics: Animals; Calcium; Drug Synergism; Gallbladder; Glucagon; Kinetics; Liver; Male; Oxygen Consumption; Perfusion; Rats; Rats, Inbred Strains; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid; Vasopressins | 1992 |
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid | 1988 |
Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC.
Topics: Angiotensin II; Animals; Bile Acids and Salts; Calcium; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Liver; Male; Mesocricetus; Protein Kinase C; Receptors, Glucagon; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid | 1995 |
Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes.
Topics: Angiotensin II; Animals; Bile; Bile Acids and Salts; Cells, Cultured; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; Isoenzymes; Kinetics; Liver; Male; Mesocricetus; Protein Kinase C; Protein Kinase C-alpha; Receptors, Glucagon; Reference Values; Taurocholic Acid; Ursodeoxycholic Acid | 1997 |
Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.
Topics: Angiotensin II; Animals; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; GTP-Binding Proteins; Keratins; Ligation; Liver; Male; Mesocricetus; Receptors, Glucagon; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1998 |